The phrase “chronic kidney disease stages” sends most men straight into a Google spiral, and what they find is usually either too clinical to be useful or so alarming it implies dialysis is around the corner. Neither is true for most patients. CKD is a spectrum — five stages defined by a single number, the eGFR — and where you sit on that spectrum determines almost everything: whether you need a specialist, whether your kidneys are still recoverable, and whether the symptoms you’re feeling are even from CKD at all. I see CKD patients every week in clinic, and the most common thing I tell them is this: the stage matters less than the trajectory. A stable Stage 3a at 55 is in better shape than a Stage 2 dropping fast at 45. This guide explains every stage in plain language, names the two numbers that genuinely matter, and tells you when CKD becomes the kind of problem that needs action this month — not next year.

What Is Chronic Kidney Disease, Really?

Your kidneys are two fist-sized filters that process roughly 180 liters (about 47 gallons) of blood every day. They strip out waste, balance your electrolytes, regulate your blood pressure, and produce hormones that build red blood cells and activate vitamin D. When that filtering capacity drops below normal for three months or more — confirmed on two separate tests — that is the formal definition of chronic kidney disease.

The word “chronic” matters here. Acute kidney injury can occur in 48 hours from dehydration, contrast dye, or sepsis, and it often reverses fully with treatment. CKD is the slow version — kidney function declining steadily over months or years, usually without the patient noticing.

The marker we use to track this decline is eGFR: estimated glomerular filtration rate. It is a calculated number based on your serum creatinine, age, and sex, expressed in mL/min/1.73m². A healthy young adult sits around 100-120. The number falls naturally with age — by roughly 1 mL/min per year after age 40 — which is why an eGFR of 75 in a 70-year-old man is not the same problem as 75 in a 35-year-old.

The 2024 KDIGO guidelines, which are the international standard for kidney disease management, define CKD as either an eGFR below 60 for three months, or evidence of kidney damage (proteinuria, abnormal imaging, or biopsy findings) at any eGFR [1]. That second clause is why some patients with a normal eGFR of 95 still get labeled as having CKD — if there is protein in their urine, the damage is already underway.

The 5 Chronic Kidney Disease Stages, Explained by eGFR

CKD has five stages, with Stage 3 split into 3a and 3b because the clinical implications differ. Here is what each stage means in practical terms.

Stage 1: eGFR 90 or above, with kidney damage

Filtration is normal, but there is structural or functional damage — usually picked up by protein in the urine or an imaging abnormality. Many men in this stage do not know they have CKD because their creatinine looks fine. The intervention here is identifying and treating the underlying cause: usually diabetes, hypertension, or recurrent kidney stones.

Stage 2: eGFR 60-89, with kidney damage

Mildly reduced filtration. Same caveat as Stage 1 — you only get this label if there is evidence of damage. An eGFR of 75 in a healthy 65-year-old with no proteinuria and no imaging changes is not CKD; it is age-appropriate filtration.

Stage 3a: eGFR 45-59 (Mild-to-moderate loss)

This is the line where CKD becomes a labeled, monitored condition that requires action. Roughly half of your kidney function is gone. Most patients still feel normal. Your primary care doctor should be checking creatinine and UACR every 6-12 months, blood pressure should be tight, and certain medications (NSAIDs, contrast dye) start needing caution.

Stage 3b: eGFR 30-44 (Moderate-to-severe loss)

This is when many men first feel a difference — fatigue, mild itching, or sleep disturbance. It is also the stage where nephrology referral becomes routine. Mineral and bone problems (low vitamin D, raised phosphate) begin to show up on bloods, and anemia from reduced erythropoietin can appear.

Stage 4: eGFR 15-29 (Severe loss)

Pre-dialysis territory. The conversation now includes preparing for kidney replacement therapy — dialysis or transplant — even if it is not yet needed. Patients in this stage need a nephrologist managing their care, not a primary care doctor doing it alone.

Stage 5: eGFR below 15 (Kidney failure)

Established kidney failure. Dialysis or transplant is required, or palliative kidney care is chosen if the patient is frail and not a candidate for replacement therapy. Symptoms — nausea, breathlessness, swelling, cognitive change — are typically prominent by this stage.

CKD Symptoms: Why Stages 1-3a Often Feel Like Nothing

Here is the single most important thing to understand about CKD symptoms: your kidneys have enormous reserve capacity. You can lose 50% of total kidney function before any symptom appears, and even at 50% loss, most men still feel completely well. By the time symptoms force a doctor’s visit, the eGFR is usually below 30 — and a great deal of damage has already accumulated.

This is why CKD is sometimes called a “silent” disease. It is also why nearly 90% of US adults with CKD do not know they have it, according to CDC surveillance data [2].

Symptoms in Stage 3b and beyond

When symptoms do appear, they tend to come in clusters. The most common patterns I see in clinic:

• Fatigue that doesn’t lift with sleep — from anemia and toxin build-up, usually the first symptom mentioned.
• Foamy or bubbly urine — protein leaking into the urine. Persistent foaming that doesn’t disperse is meaningful.
• Ankle and lower-leg swelling — fluid retention from reduced filtration and protein loss.
• Itching — particularly at night, from raised phosphate and uremic toxins.
• Poor appetite, metallic taste, nausea — uremia accumulating, typically Stage 4-5.
• Breathlessness on exertion — fluid overload or anemia, often the combination.
• Nocturia — waking 2 or more times per night to urinate, often dismissed as prostate-related.

The Two Numbers That Matter More Than the Stage Itself

If you take only one thing from this article, take this: knowing your CKD stage is incomplete information. Two patients with identical eGFRs can have completely different five-year outcomes. The numbers that actually predict your trajectory are these.

Number 1: Your urine albumin-creatinine ratio (UACR)

This is a simple urine test that measures how much protein is leaking through your kidney filters. It is the single strongest predictor of CKD progression — stronger than eGFR alone [3]. Categories:

• A1 (Normal): UACR less than 30 mg/g
• A2 (Moderate): UACR 30-300 mg/g — “microalbuminuria”
• A3 (Severe): UACR above 300 mg/g — “macroalbuminuria”

A man with Stage 3a CKD and A1 albuminuria has a markedly different risk profile than a man with Stage 2 CKD and A3 albuminuria. The KDIGO “heatmap” combines eGFR and UACR to assign a risk category (low, moderate, high, very high) — and that risk category is what determines your monitoring frequency and treatment intensity.

Number 2: Your rate of eGFR decline per year

A stable eGFR is a good eGFR, even if the number itself is low. The normal age-related drop is roughly 1 mL/min per year. A drop of 3-5 mL/min per year is concerning. A drop above 5 mL/min per year is rapid progression and demands urgent assessment.

This is why I tell patients to keep their own running log of eGFR results. Compare each new result not just to the reference range but to your own previous numbers. A trajectory of 65 → 62 → 58 over three years is a slow drift. The same numbers reached in twelve months — 65 → 62 → 58 — is something completely different and needs nephrology input now.

What Causes CKD in Men: The Top 5 Drivers I See

The causes of CKD have shifted over the last 30 years. In men presenting today, this is the order of frequency I see, and it broadly matches US and international registry data [4].

1. Diabetes (roughly 40% of cases)

Diabetic nephropathy is the leading cause of end-stage kidney disease in the US. Years of high blood glucose damage the small filtering vessels in the kidney (glomeruli). The first warning sign is microalbuminuria — long before eGFR starts dropping. Every diabetic man should have a UACR test annually, no exceptions.

2. Hypertension (roughly 25% of cases)

Untreated or under-treated high blood pressure scars the kidney’s small arteries and reduces filtration over years. The link runs both ways: hypertension causes CKD, and CKD causes hypertension. Tight BP control under 130/80 mmHg is the single most evidence-backed intervention to slow progression in non-diabetic CKD.

3. Kidney stones and obstructive uropathy (roughly 10-15%)

Recurrent stones, prolonged obstruction from an enlarged prostate, or chronic urinary retention all damage the kidney over time. This is the urological piece I see in my own clinic. A man with a single stone and no obstruction is at minimal CKD risk. A man with three stones in five years, particularly with any episode of obstruction or infection, has meaningful CKD risk and needs his eGFR monitored.

4. Glomerulonephritis and inherited disease (roughly 10%)

IgA nephropathy, focal segmental glomerulosclerosis, polycystic kidney disease, and Alport syndrome. These usually present with proteinuria, blood in the urine, or a strong family history. They are nephrologist territory from diagnosis onward.

5. Drug-induced and miscellaneous (roughly 10%)

Long-term NSAID use (ibuprofen, naproxen) is a widely underappreciated cause. Lithium, certain chemotherapy agents, and repeated contrast exposure also contribute. I have seen otherwise healthy men in their 60s with Stage 3a CKD whose only identifiable cause was a decade of daily ibuprofen for joint pain.

If you have recurrent kidney stones or persistent blood in your urine, both deserve a proper workup — not just for stone or bladder reasons, but to identify CKD early.

Slowing CKD Progression: What Actually Works

The good news about CKD is that progression is not a foregone conclusion. Three interventions have strong, high-quality evidence behind them. The other things you read about online — special diets, supplements, herbal remedies — range from “minor effect at best” to “actively harmful.”

Lever 1: Blood pressure under 130/80 mmHg

The SPRINT trial and subsequent KDIGO 2024 guidance both support a systolic target under 130 mmHg in most CKD patients [1]. The preferred first-line agents are ACE inhibitors (e.g. ramipril, lisinopril) or ARBs (e.g. losartan, telmisartan). These medications do more than just lower BP — they reduce protein leakage and slow filtration loss directly. If you have CKD and are not on one of these, that conversation needs to happen at your next visit.

Lever 2: Glycaemic control if diabetic

An HbA1c around 7% (53 mmol/mol) is the typical target for diabetic CKD, though this gets individualized. Aggressive control below 6.5% sometimes does more harm than good in older patients due to hypoglycemia risk. The point is consistency: erratic glucose with frequent highs damages the kidney filters more than a steadily controlled higher target.

Lever 3: SGLT2 inhibitors (the genuine breakthrough of the last decade)

Dapagliflozin and empagliflozin were originally developed as diabetes drugs but have been shown to slow CKD progression by roughly 40% in eligible patients, including non-diabetic CKD [5]. The DAPA-CKD and EMPA-KIDNEY trials are the strongest renal protection evidence we have seen in 20 years. If you have CKD with proteinuria and you are not on one of these, ask your doctor specifically whether you should be.

What else helps (smaller effects, but real)

• Reducing sodium below 2,000 mg per day (about 1 teaspoon of salt) — helps BP control and reduces fluid retention.
• Maintaining adequate hydration — around 2-2.5 liters per day (about 70-85 fl oz) for most men. Not excessive — there is no benefit beyond this and risk of hyponatremia.
• Stopping NSAIDs — ibuprofen, naproxen, diclofenac. Acetaminophen (paracetamol) is safe up to 3 g/day. This single switch is one of the most impactful changes I prescribe.
• Treating proteinuria-driving conditions — gout, hypothyroidism, sleep apnea.

When to See a Nephrologist vs. Stay With Your Primary Doctor

Most early CKD is managed perfectly well by primary care. Specialist referral becomes the right call at specific thresholds, and over-referral is its own problem — it congests nephrology clinics and delays the patients who genuinely need a specialist. The KDIGO criteria for referral are clear [1]:

• eGFR below 30 (Stage 4 or 5) — automatic referral.
• UACR above 300 mg/g regardless of eGFR — heavy proteinuria needs specialist input.
• eGFR drop above 5 mL/min in 12 months — rapid progression needs urgent assessment.
• Persistent hematuria with proteinuria — possible glomerulonephritis, needs biopsy consideration.
• Resistant hypertension — BP not controlled on 3 or more medications including a diuretic.
• Suspected hereditary disease — polycystic kidneys, family history of dialysis.
• Recurrent kidney stones with declining eGFR — urology and nephrology often share care here.

Stage 1, 2, and 3a CKD without proteinuria are primary-care conditions in almost every guideline. If you are in those stages and have been told “you have CKD, see a kidney specialist immediately,” that is not wrong, but it is not the only reasonable approach either.

Red Flags: When CKD Needs Urgent Attention

For any of the above, contact your doctor the same day or attend the emergency room. The kidney injury that starts as a slow decline can accelerate suddenly under the right combination of dehydration, infection, or a wrong medication.

Frequently Asked Questions

Dr. Muhammad Khalid

MBBS · FCPS (Urology) · MCPS (Gen. Surgery) · CHPE · CRSM · IMC #539472

Specialist urologist with 11+ years of clinical experience across tertiary teaching hospitals. Trained at Lady Reading Hospital and Khyber Teaching Hospital, Peshawar. Author of 5 peer-reviewed international publications in Cureus, WJSA, and AJBS. Procedural expertise: URS, PCNL, RIRS, TURP, TURBT, and major open urological surgery. Full profile →

This article is for educational purposes only and does not constitute medical advice. Always consult your physician or urologist for diagnosis and treatment decisions specific to your condition.